Introduction
The myocardin family members MRTF-A and -B (MRTF-A/B; also known as megakaryocytic acute leukemia and megakaryoblastic leukemia-1/2) are well-established co-activators of serum response factor (SRF) (1, 2) . Myocardin expression is restricted to smooth and cardiac muscle cells, whereas MRTF-A/B are expressed ubiquitously. The activity of MRTF-A/B is regulated by their translocation from the cytosol to the nucleus, which is triggered by the activation of Rho family proteins (2) . Like myocardin, MRTF-A/B are reported to contribute to skeletal, cardiac and smooth muscle differentiation (3) . Their importance in mammary myoepithelial differentiation (4, 5) and the epithelial-mesenchymal transition (6) has been established, but their functions in other non-muscle cells are still unclear.
We recently demonstrated that MRTF-A/B are required for the formation of stress fibers and focal adhesions by co-ordinately activating the transcription of several genes that encode cytoskeletal/focal adhesion proteins, including caldesmon, tropomyosin, vinculin and zyxin, in an SRF/CArG box-dependent manner, leading to the reorganization of the actin cytoskeleton (7) . Another research group has shown that MRTF-A contributes to the expression of the SRF-targeted actin cytoskeletal genes tropomyosin, zyxin and vinculin (8) . Using computational analysis and molecular biological validation, Sun et al. (9) demonstrated that a number of SRF target genes with a CArG box in their promoter are involved in the actin cytoskeleton. Moreover, SRF is crucial for the organization of the actin cytoskeleton and the assembly of focal adhesions in embryonic stem cells (25) . Thus, SRF and the MRTFs are implicated in the regulation of actin cytoskeletal functions via their transcriptional control of genes encoding cytoskeletal components.
Various oncogenes cause transformation-associated changes in the actin cytoskeleton (10, 11) . These alterations correlate with the reduced expression of various actin cytoskeletal proteins, for example a-actinin (12, 13) , gelsolin (14) , profilin (15) , vinculin (16) and tropomyosin (17, 18) . Re-expression of these proteins reverses many features of the transformed phenotypes, including their lack of stress fibers and focal adhesions, escape from contact inhibition, acquisition of anchorageindependent growth and tumorigenicity in nude mice. In addition, we found that the downregulation of caldesmon expression in srctransformed cells and several cancer cell lines enhances the formation of podosomes/invadopodia (19, 20) . Thus, although the reduction of various actin cytoskeletal proteins is critical event in tumorigenesis, contribution of the MRTFs to this process has not been clearly determined. Here, we examined that involvement of the MRTFs in disorganization of the actin cytoskeleton and oncogenic property in v-ras-and v-srctransformed cells and then demonstrated that attenuation of MRTFs' nuclear translocation/retention causes the disorganization of the actin cytoskeleton and the tumorigenesis in the transformed cells.
Materials and methods

Cell culture
For in vitro experiments, we used a rat intestinal epithelial (RIE) cell line, which has a non-transformed phenotype (21) . The RIE cells harboring either v-H-ras (RIE-ras) or v-src (RIE-src) were described previously (22) . All cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS).
Expression vectors and transfection
The coding regions of mouse MRTF-A, MRTF-B and human SRF were amplified by PCR and cloned into pcDNA3.1 (þ) (Invitrogen, Carlsbad, CA). The Flag-tag or HA-tag sequence was fused to the 5# end of the coding sequences of these genes by polymerase chain reaction. Constitutively active (CA)-MRTF-A and CA-MRTF-B were made by truncating the N-terminal RPEL motifs, as described previously (6) . The expression vectors were transiently transfected into the RIE-ras and RIE-src cells using TransIT-LT1 Transfection Reagent (Mirus, Madison, WT). To establish stable cell lines expressing CA-MRTF-A, we used pcDNA6/TR (Invitrogen, Carlsbad, CA) as an expression vector for CA-MRTF-A, and cells stably transfected with pcDNA6/TR-CA-MRTF-A were selected with 5 lg/ml blasticidin (InvivoGen, San Diego, CA).
Western blot analysis
The cells were lysed with sodium dodecyl sulfate (SDS) sample buffer [50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 0.1 M dithiothreitol and 0.05% bromophenol blue] and boiled for 5 min. SDS-polyacrylamide gel electrophoresis was performed using 10% acrylamide gel, and separated proteins were transblotted onto a polyvinylidene difluoride membrane. Antibody was diluted 2000-fold with Can Get Signal Immunoreaction Enhancer Solution (TOYOBO, Osaka, Japan). Anti-tropomyosin (TM311; Sigma, St Louis, MO), anti-a-tubulin (DM1A; Sigma), anti-SRF (G-20, Santa Cruz Biotechnology, Santa Cruz, CA), anti-HA (3F10; Roche, Mannheim, Germany) and anti-FLAG (Sigma) antibodies were purchased. Anti-MRTF-A and anti-MRTF-B antibodies were produced in New Zealand rabbits and purified as described previously (7, 23) .
Immunocytochemistry
The cells grown on cover slips were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min at room temperature and then permeabilized with 0.1% Triton X-100 in PBS. Cells that were transiently transfected with CA-MRTF-A, CA-MRTF-B or SRF were fixed 2 days after the transfection. The fixed cells were incubated with 200-fold diluted antibody, followed by the appropriate 400-fold diluted secondary antibody. To label actin filaments or nuclei, respectively, Alexa 568-conjugated phalloidin (Molecular Probes, Eugene, OR) or Hoechst33342 (Molecular Probes, Eugene, OR) was added to the secondary antibody solution.
Nuclear translocation of MRTF-A/B
The cells were serum starved by incubation in serum-free DMEM for 24 h, stimulated by DMEM with 10% FCS and then fixed in 4% paraformaldehyde. Cells were then immunostained for MRTF-A or MRTF-B and Hoechst. For each condition, the cells were divided into three groups according to their MRTF-A or MRTF-B localization (cytosolic, cytosolic and nuclear and nuclear) and counted, and the percentage of cells belonging to each category was graphed.
Invasion and migration assays
Cell invasiveness was measured using Matrigel-coated Boyden chambers (BD BioCoat Matrigel Invasion Chambers, BD Biosciences, Sun Jose, CA), as described previously (20) . The lower chambers were filled with DMEM plus 10% FCS, and the cells were placed in the insert chambers, which contained DMEM Ã P , 0.05, ÃÃ P , 0.01 and ÃÃÃ P , 0.001 by Student's t-test.
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without FCS. After 24 h of incubation, cells that had invaded through the Matrigel were fixed with 4% paraformaldehyde, stained with hematoxylineosin and counted. Cell migration was measured using BD BioCoat Control Inserts (BD Biosciences, Sun Jose, CA), which are not coated with Matrigel, as in the invasion assay, except with a shorter incubation time (12-24 h), as described previously (19) .
Wound healing assay
The cells were grown to confluence and treated with 1 lg/ml of mitomycin C (Nacalai Tesque, Kyoto, Japan) for 2 h. The wound was created by scraping with pipette tip and then wound healing was assayed 20 h after the scraping.
Colony formation assay
Anchorage-independent growth was assessed by the cells' ability to form colonies in soft agar. The cells (5 Â 10 3 per well) were suspended in 0.4% agarose containing DMEM plus 10% FCS and plated onto a 0.66% agarose bottom layer in six-well plates. After 10 days of incubation, the numbers of colonies (.50 lm) were counted.
Tumorigenesis assays
All animal studies were approved by the Institutional Committee for Animal Experiments of Osaka University and conducted in accordance with their principles and procedures. Seven-week-old male BALB/c nu/nu nude mice were purchased from Japan SLC (Hamamatsu, Japan). All the mice were maintained under specific pathogen-free conditions at the Center for Animal Experimentation, Osaka University Graduate School of Medicine. Regular laboratory food and tap water were freely available to the animals. Cells (1 Â 10 7 cells in 200 ll of PBS) were injected subcutaneously into the back of each mouse, and tumor size was measured every 4 days. On the 28th day after the injection, the mice were euthanized.
Liver metastases
Six-week-old male BALB/c nu/nu nude mice were anesthetized with Nembutal (pentobarbital sodium) (Dainippon Sumitomo Pharma, Osaka, Japan) and the spleen exposed via an abdominal incision. The parental RIE cells, RIE-ras or RIE-src cells, or their cognate lines expressing CA-MRTF-A, were injected into the spleen at 1 Â 10 7 cells/100 ll PBS, and the incision was closed. The mice were killed 10 days after the injection, and the livers were examined for hepatic metastases. The control livers did not contain metastases. Tumor weight was estimated by subtracting the average weight of the control livers from the average weight of each group of experimental livers.
Immunoprecipitation
Cells were lysed with lysis buffer [PBS (pH 7.5) containing 0.5% Triton-X 100, 1 mM ethylenediaminetetraacetic acid, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM b-glycerophosphate and protease inhibitor cocktail tablets (Roche, Mannheim, Germany)] and incubated on ice for 15 min. The lysates were briefly sonicated and then centrifuged to remove the cell debris. The resulting supernatants were incubated with anti-FLAG M2-agarose (Sigma) overnight at 4°C. To retrieve the immunocomplexes, the agarose beads were washed four times with the lysis buffer, and the proteins were eluted in SDS sample buffer.
Results
v-Ras-and v-src-induced changes in the actin cytoskeleton
The parental RIE cells exhibited fully extended stress fibers and had a flattened cell shape. In contrast, v-ras-transformed RIE (RIE-ras) cells had a spindle-like shape with thin stress fibers ( Figure 1A ). Instead of forming stress fibers, the v-src-transformed RIE (RIE-src) cells predominantly extended invadopodia containing dot-shaped F-actin clusters, as previously observed in src-transformed fibroblasts (19, 20) (Figure 1A) .
To understand the mechanisms of the v-ras-and v-src-induced reorganization of the actin cytoskeleton, we examined the expression levels of several cytoskeletal proteins, all of which are downregulated in certain transformed and cancer cells (12, 13, (16) (17) (18) 20) . Compared with the parental RIE cells, the levels of caldesmon and tropomyosin, which are critically involved in stress fiber and invadopodium formation (19, 20) , were markedly reduced in the RIE-ras and RIE-src cells ( Figure 1B and C) . The levels of a-actinin in the RIE-ras and RIE-src cells and vinculin in the RIE-src cells were slightly reduced, but these changes were not statistically significant ( Figure 1B and C) . The level of gelsolin was significantly increased in RIE-src cells. The level of a-tubulin was not changed among the RIE, RIE-ras and RIE-src cells ( Figure 1B and C) .
Next, we assessed the levels of SRF, MRTF-A and MRTF-B because these three proteins are known regulators of caldesmon, tropomyosin and other actin cytoskeletal proteins (7) . Unexpectedly, the expression levels of MRTF-A/B were increased in the RIE-ras and RIE-src cells, whereas the level of SRF was markedly reduced ( Figure 1C) . 
MRTF-A/B suppress the oncogenic properties
Suppression of nuclear translocation of MRTF-A and MRTF-B in RIE-ras and RIE-src cells The activities of MRTF-A and MRTF-B are tightly linked to their subcellular localization (2) . Since the levels of endogenous MRTF-A and MRTF-B were increased in the transformed cells, we investigated their localization after serum stimulation. In the parental RIE cells, MRTF-A was predominantly localized to the cytosol after a 24 h serum starvation. Upon serum stimulation, MRTF-A was translocated into the RIE nuclei within 10 min, and it remained in the nucleus of .50% of the cells even after 60 min (Figure 2A) . In contrast, ,50% of the RIE-ras cells exhibited any nuclear translocation of MRTF-A, and MRTF-A remained in the cytosol of almost all the RIE-ras cells after 60 min of stimulation (Figure 2A ). In the RIE-src cells, MRTF-A was transiently translocated into the nucleus of only 20% of the cells, and it immediately returned to the cytosol (Figure 2A) . The results for MRTF-B were similar to those for MRTF-A ( Figure 2B ). Thus, the nuclear retention time of MRTF-A/B was much shorter in RIE-ras and RIE-src cells than in the parental RIE cells, suggesting that the MRTF-A/B activities were much lower in the RIE-ras and RIE-src cells than in the RIE cells, although their expression levels were increased in the transformed cells.
v-Ras-and v-src-induced disorganization of the actin cytoskeleton was rescued by MRTF-A and MRTF-B, but not by SRF To determine whether the reduced SRF expression and/or the decreased nuclear translocation of MRTFs was responsible for the actin cytoskeletal disorganization in RIE-ras and RIE-sac cells, we expressed exogenous, CA forms of MRTF-A and MRTF-B, and overexpressed SRF in RIE-ras and RIE-src cells and evaluated their effects on actin organization. In the CA-MRTF-A and CA-MRTF-B constructs, the N-terminal RPEL motifs, which are required for the molecules' retention in the cytoplasm via their binding of monomeric actin (2) , are deleted. Therefore, the CA-MRTF-A/B proteins predominantly accumulate in the nucleus, without any need for the Rho signal that causes translocation of the wild-type molecules (2) . Compared with the surrounding non-transfected cells, RIE-ras cells expressing CA-MRTF-A formed thick actin fibers that exhibited a higher fluorescence intensity of phalloidin staining ( Figure 3A ). In the RIE-src cells, CA-MRTF-A expression also augmented actin fiber formation and reduced the formation of invadopodia ( Figure 3A) . CA-MRTF-B expression in the RIE transformants also enhanced the formation of thick actin fibers and reduced that of invadopodia ( Figure 3B ). On the other hand, the overexpression of SRF did not rescue the disorganized actin cytoskeleton in either the RIE-ras or RIE-src cells ( Figure 3C ). These data suggest that the suppression of MRTF-A/B's nuclear localization is the primary cause of the morphological and actin cytoskeletal changes induced by the v-ras-and v-src-transformation.
Ectopic CA-MRTF-A expression reduced the v-ras and v-src transformants' invasiveness and anchorage-independent colony formation
To analyze whether the expression of exogenous CA-MRTF-A/B could reduce the malignant properties of RIE-ras and RIE-src cells, we isolated stable cell lines expressing CA-MRTF-A from transfected RIE-ras cells (ras C2 and ras C6) and RIE-src cells (src C9 and src C14). In these cell lines, the levels of caldesmon and tropomyosin were significantly increased ( Figure 4A and B) from those in the nontransfected RIE-ras and RIE-src cells. Furthermore, as observed in the transiently transfected CA-MRTF-A/B transformants, their morphology and actin organization had largely reverted to those of the parental RIE cells ( Figure 4C) .
We measured the invasiveness of these cells using a Matrigelcoated Boyden chamber. RIE-ras and RIE-src cells actively passed through the Matrigel, but markedly fewer CA-MRTF-A-expressing cells did so, in all the lines tested ( Figure 5A ). Since the invasion activity measured by this assay includes the ability both to degrade the Matrigel and to migrate, we evaluated the cell migration activity alone, using a Boyden-chamber without Matrigel coating. In contrast to the results of the Matrigel invasion assay, there were no significant differences between the CA-MRTF-A-expressing cell lines and their parental cells in the cell migration assay ( Figure 5B ). We also evaluated the cell migration activity by wound healing assay and confirmed that CA-MRTF-A expression did not affect the migration activity in these cells ( Figure 5C ). Taken together, these results suggest that CA-MRTF-A suppresses invasiveness by inhibiting the cells' ability to degrade Matrigel.
Anchorage-independent growth is another characteristic phenotype of transformed cells. We found that the parental RIE cells failed to establish colonies in soft agar, whereas the RIE-ras and RIE-src cells actively proliferated and formed large colonies ( Figure 5D ). In the CA-MRTF-A-expressing cell lines, the colony formation in soft agar was markedly reduced (Figure 5D and E) . Thus, the transformed phenotypes of the RIE-ras and RIE-src cells were greatly suppressed by the expression of ectopic CA-MRTF-A.
Decreased tumorigenicity of CA-MRTF-A-expressing cells
Using a mouse model, we analyzed the effect of ectopic CA-MRTF-A expression on the RIE-ras and RIE-src cells' tumorigenicity in vivo. When RIE-ras and RIE-src cells were subcutaneously injected into nude mice, they formed tumors that continued to grow until the animals were killed, at 28 days postinjection ( Figure 6A and B) . Although the CA-MRTF-expressing ras C2 and ras C6 cells also formed tumors, their volumes were much smaller ( Figure 6A and  B) . Similarly, tumor growth was severely suppressed in the src C9 and src C14 cells, as compared with RIE-src cells. Thus, the expression of CA-MRTF-A in ras-and src-transformed cells suppressed their tumorigenicity in vivo. To confirm the expression of FLAG-CA-MRTF-A in the CA-MRTF-A expressing clones (ras C2, ras C6, src C9 and src C14), immunoprecipitation was performed using an anti-FLAG antibody, followed by western blotting with the anti-MRTF-A antibody. To compare the expression levels of caldesmon and tropomyosin between the CA-MRTF-Aexpressing clones and their parental RIE-ras or RIE-src cells, the total proteins were extracted from these cells and western blotting was performed using anti-caldesmon, anti-tropomyosin and anti-a-tubulin antibodies. (C) CA-MRTF-A-expressing clones and their parental RIE-ras and RIE-src cells were stained with phalloidin; scale bar is 20 lm.
MRTF-A/B suppress the oncogenic properties
Decreased metastatic activity of CA-MRTF-A-expressing cells
We further investigated the effect of CA-MRTF-A expression on metastasis by injecting cells into the spleen of nude mice and examining the liver for metastases. Injecting RIE-ras or RIE-src cells into the spleen led to the formation of numerous metastatic tumors in the liver. By the end of the experiment, 28 days after the injection, the tumor cells had almost completely displaced the normal liver cells in these mice ( Figure 6C ). In contrast, the intrasplenic injection of ras C2 and ras C6 cells resulted in small metastatic tumors that were scattered throughout the liver ( Figure 6C) . Similarly, the intrasplenic injection of src C9 and src C14 cells led to small metastatic foci in the liver ( Figure 6C ). To quantify the degree of metastasis, we measured the tumor weights by subtracting the average weight of normal livers from the average weight of livers bearing metastases. The CA-MRTF-A-expressing cell lines caused a much smaller metastatic tumor burden in the liver than the RIE-ras or RIE-src cells ( Figure 6D) . Thus, CA-MRTF-A expression suppressed the metastatic activity of both ras-and src-transformed cells.
Discussion
Accumulating evidence indicates that the SRF/MRTFs are pivotal regulators of actin organization in non-muscle cells (6) (7) (8) (9) 20) . Schratt et al. (24) demonstrated, using SRF-deleted ES cells, that SRF is required for actin cytoskeletal organization and focal adhesion assembly. We previously reported that a knockdown of MRTF-A/B leads to severe defects in the formation of stress fibers and focal adhesions in NIH 3T3 fibroblasts (7) . In RIE-ras and RIE-src cells, the expression levels of MRTF-A/B were unexpectedly increased ( Figure 1B and C) , whereas their nuclear translocation was severely suppressed (Figure 2) . We do not know why MRTFs' levels were increased in the transformed cells, but the weak nuclear translocation and retention of MRTFs suggests that their functions as a transcription cofactor would be attenuated in the transformed cells. In accordance with this, the transformed cells showed defect in the actin cytoskeleton and marked decreases in caldesmon and tropomyosin, whose expression was tightly regulated by MRTFs (6,7) . Further, CA-MRTF-A rescued The invasion activities of CA-MRTF-Aexpressing clones (ras C2, ras C6, src C9 and src C14) and their parental RIE-ras and RIE-src cells were measured using a Matrigel-coated Boyden-chamber. Statistical analysis was carried out with Student's t-test for three independent experiments. Asterisks indicate significant differences, Ã P , 0.05. (B) The migratory capabilities of CA-MRTF-A-expressing clones and their parental RIE-ras and RIE-src cells were measured using a Matrigel-uncoated Boyden chamber. (C) The migratory capabilities of CA-MRTF-A-expressing clones and their parental RIE-ras and RIE-src cells were measured by wound healing assay. (D) CA-MRTF-Aexpressing clones and parental RIE-ras and RIE-src cells were cultured in soft agar to assess anchorage-independent growth. Photographs of the colonies that formed are shown; scale bar is 400 lm. (E) The colonies with a diameter .25 lm were counted. Statistical analysis was carried out with Student's t-test for three independent experiments. Asterisks indicate significant differences, Ã P , 0.05.
T.Yoshio et al. . Overexpression of SRF, however, did not rescue the stress fiber formation ( Figure 3C ), suggesting that the reduced expression of SRF was not a direct cause of the actin cytoskeletal defects. Taken together, our data indicate that the weak nuclear retention of MRTF-A/B is the principal cause of the disorganized actin cytoskeleton of RIE-ras and RIE-src cells. The nuclear localization of MRTF is controlled by a dynamic balance between its nuclear import and export (6, 25) . In the RIE-ras and RIEsrc cells, the nuclear translocation of endogenous MRTF-A/B prompted by serum stimulation was attenuated, and their nuclear retention times were somewhat shorter than in parental RIE cells (Figure 2 ), indicating either decreased nuclear import or increased export. Rho is a key regulator of MRTF-A/B nuclear translocation (2) , and its function is attenuated by the downregulation of Rho-kinase through a mitogenactivated protein kinase/extracellular-signal-regulated kinase kinase (MEK)-dependent pathway in v-ras and v-src transformants (26, 27) . Furthermore, a recent report showed that the serum-induced phosphorylation of MRTF-A by the extracellular signal-regulated kinase 1/2 pathway directly inhibits its nuclear localization (28) . Since extracellular signal-regulated kinase 1/2 are downstream of MEK, these data suggest that activation of the MEK-extracellular signal-regulated kinase pathway in v-ras-and v-src-transformed cells may be responsible for the inhibited nuclear import or enhanced export of MRTF-A/B. We preliminarily evaluated the effect of MEK inhibitor U0126 on MRTF-A/B nuclear translocation in the RIE-ras and RIE-src cells, but the weak nuclear translocation and retention of MRTF-A/B was not rescued by U0126 (data not shown). Further experiments are necessary for working out the mechanisms underlying the attenuation of MRTF-A/B nuclear translocation.
We previously reported that caldesmon controls the formation of podosomes/invadopodia by competing with Arp2/3 for its binding site on F-actin, thereby inhibiting actin nucleation and polymerization (20) . The podosome/invadopodium is an adhesion structure associated with cell invasiveness through the degradation of extracellular matrix. It is a feature of a variety of invading cells, including macrophages, osteoclasts, oncogenic transformants and cancer cells. Caldesmon overexpression inhibits podosome/invadopodium formation and therefore suppresses cancer-cell invasiveness (19, 20) . In the RIEsrc cells, CA-MRTF-A expression upregulated the caldesmon level, thereby rearranging the actin cytoskeleton and reducing the number of invadopodia ( Figure 5A ), which would contribute to CA-MRTF-A's suppression of the cells' invasiveness.
Tropomyosin is a known class II tumor suppressor. It inhibits colony formation in soft agar and tumorigenesis in nude mice by v-rasand v-src-transformed fibroblasts (17, 18) . In RIE-ras cells, however, the increased expression of tropomyosin alone does not inhibit colony formation (29) . In contrast, CA-MRTF-A expression upregulated both tropomyosin and caldesmon in RIE-ras and RIE-src cells, inhibiting their colony formation in soft agar and tumorigenesis in nude mice ( Figure 5D and E). In addition to tropomyosin, several actin cytoskeletal proteins are reported to inhibit the anchorage-independent growth and tumorigenicity of oncogenic transformants. Because SRF and the MRTFs regulate the expression of a large number of actin cytoskeletal genes, a good explanation for our findings is that caldesmon and other MRTF/SRF-regulated proteins mediate the anti-oncogenic properties of MRTF-A/B.
Metastasis is a complex, multi-step process that includes the release of cancer cells from the primary focus, their invasion of the circulatory system, adherence to the basement membrane of target organs, invasion through the basement membrane and finally the growth of secondary tumors in target sites (30) . In our metastasis assay, CA-MRTF-A markedly suppressed the metastasis to the liver of RIE-ras and RIE-src cells injected into the spleen (Figure 6C and D) . The results of our invasion and colony formation assays indicate that CA-MRTF-A suppresses the invasion and tumor-growth steps of the metastatic process. In contradiction to our finding, however, Medjkane et al. (31) recently reported that a knockdown of MRTF-A/B or SRF tightly suppresses experimental metastasis of MDA-MB231 breast carcinoma and B16F2 melanoma cells, but that overexpression of activated MRTF-A increases the metastatic activity of B16F2 cells. This discrepancy may be owing to differences in the metastasis assays. Their assay involved injecting the cells directly into the bloodstream via the tail vein of the host mouse. The cells subsequently adhered to the basement membrane of the lung. Thus, their experimental metastatic paradigm is largely dependent on the adhesive properties of the metastatic cells. Because the depletion of SRF and MRTF results in the disassembly of focal adhesions and reduced stress-fiber formation (7, 24) , the low invasiveness and metastatic rate of the SRF-or MRTF-A/B knockdown cells might have been caused by their reduced cell adhesiveness and motility. Our assay, which we believe is much closer to natural metastatic processes, supports the following proposal: moderate suppression of MRTF-A/B activity in v-ras-and v-src-transformed cells by the attenuation of MRTF-A/B nuclear localization leads to actin cytoskeletal reorganization without severe defects in cell motility. This results in the cells' acquiring high invasiveness, successful anchorage-independent growth and tumorigenicity.
In conclusion, we showed here that the suppression of MRTF-A/B activity is a key step in cell transformation by oncogenic ras and src. MRTF-A/B suppress invasion activity, anchorage-independent growth, tumorigenicity and metastasis by regulating the actin cytoskeletal organization. Although future investigation is needed, our results provide new insights into the anti-oncogenic properties of MRTF-A/B.
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